VALTREX

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, New Zealand, Nigeria, Poland, Romania, Singapore, Spain, Turkey, UK.

Active ingredients

The drug VALTREX contains one active pharmaceutical ingredient (API):

1	Valaciclovir UNII G447S0T1VC - VALACYCLOVIR HYDROCHLORIDE
	Valaciclovir, an antiviral, is the L-valine ester of aciclovir. Valaciclovir is rapidly and almost completely converted in man to aciclovir and valine. Aciclovir is a specific inhibitor of the herpes viruses with in vitro activity against herpes simplex viruses (HSV) type 1 and type 2, varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr Virus (EBV), and human herpes virus 6 (HHV-6).
	Read more about Valaciclovir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VALTREX Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AB11	Valaciclovir	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
Discover more medicines within J05AB11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5480K, 6280M, 8064K, 8133C, 8134D, 9568N
BR	Câmara de Regulação do Mercado de Medicamentos	510608401111314, 510608402116311
CA	Health Products and Food Branch	02219492, 02246559
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	24.450-04-02
EE	Ravimiamet	1016301, 1529513, 1539862, 1539873, 1539884, 1539895, 1680757, 1680768, 1680779, 1680780, 1680791, 1680803, 1831003
ES	Centro de información online de medicamentos de la AEMPS	61240, 61241
FI	Lääkealan turvallisuus- ja kehittämiskeskus	175612, 184598, 374397, 377333
GB	Medicines & Healthcare Products Regulatory Agency	106859, 146911, 147492, 21860, 21862, 398806, 398807
HK	Department of Health Drug Office	49389
IE	Health Products Regulatory Authority	51800, 51842, 51865, 58818
IL	מִשְׂרַד הַבְּרִיאוּת	3166, 3383
JP	医薬品医療機器総合機構	6250019D1020, 6250019F1020
LT	Valstybinė vaistų kontrolės tarnyba	1002787, 1059619, 1059620, 1059621, 1059622, 1060083, 1068921, 1087919
NG	Registered Drug Product Database	04-8114
Switch country to Nigeria in order to find specific presentations of VALTREX
NZ	Medicines and Medical Devices Safety Authority	7349, 7350, 7351
PL	Rejestru Produktów Leczniczych	100081024
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65100001, W65100002, W65100003, W65100004, W65100005, W65100006
SG	Health Sciences Authority	08229P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522092505, 8699522092512, 8699522097524
US	FDA, National Drug Code	0173-0565, 0173-0933